Search Browse Earnings

C21 Investments Inc.

OTC:CXXIFOTC:CWLXF

Medicinal Chemicals & Botanical Products·VANCOUVER

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$28.3M

-2.1% YoY

FY 2025

Adj. EBITDA

$2.9M

10.2% margin

FY 2025

Net Income

-$3.3M

-11.7% margin

FY 2025

EPS (Diluted)

-$0.03

FY 2025

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$2.4M

FY 2025

Total Debt

$2.0M

FY 2023

Net Cash

$381,859

FY 2023

Enterprise Value

—

Debt / EBITDA

-0.1x

FY 2025

EV / EBITDA

—

Employees

—